A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects

NCT04183686 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ACT-1014-6470 (SAD)
DRUG: ACT-1014-6470 (MAD)
DRUG: Placebo (SAD)
DRUG: Placebo (MAD)
DRUG: 14C-ACT-1014-6470 microtracer
DRUG: 14C-ACT-1014-6470 microtracer placebo

Sponsor

Idorsia Pharmaceuticals Ltd.